Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Rituximab + Prednisone in AIHA
NCT01345708Phase 2Completed
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Jan 2009
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in autoimmune hemolytic anemia (AIHA), cold agglutinin disease (CAD), sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Started Jan 2009; status: completed.
02
Drugs
rituximab
03
Conditions
autoimmune hemolytic anemia (AIHA)cold agglutinin disease (CAD)
Beyond the preview
Go deeper on NCT01345708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345708.